Low dosage of arsenic trioxide (As2O3) inhibits angiogenesis in epithelial ovarian cancer without cell apoptosis

Arsenic trioxide (As2O3) induces cell apoptosis and reduces the invasive and metastatic activities in various cancer types. However, the role of As2O3 in ovarian cancer angiogenesis remains unclear. In this study, we investigated the role of As2O3 in ovarian cancer angiogenesis and found that a low concentration of As2O3 causes no effects on epithelial ovarian cancer cell viability or apoptosis. Moreover, we found that As2O3-treated epithelial ovarian cancer cells demonstrate a reduced tube formation of endothelial cells in Matrigel. In addition, As2O3-treated epithelial ovarian cancer cells show a decreased VEGFA, VEGFR2 and CD31 mRNA expression. As per the underlying mechanisms involved in As2O3 treatment, we found that As2O3 inhibits VEGFA and VEGFR2 expression that thereby inhibits the VEGFA–VEGFR2–PI3K/ERK signaling pathway. This leads to a suppression in both VEGFA synthesis and angiogenesis-related gene expression. A decreased VEGFA synthesis and secretion also inhibits the VEGFA–VEGFR2–PI3K/ERK signaling pathway in human umbilical vein endothelial cells (HUVECs). In summary, our results may provide strategies for the use of As2O3 in the prevention of tumor angiogenesis.

[1]  P. Carmeliet,et al.  Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.

[2]  M. Trani,et al.  To sprout or to split? VEGF, Notch and vascular morphogenesis. , 2011, Biochemical Society transactions.

[3]  Jianping Zhang,et al.  Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells. , 2014, Toxicology letters.

[4]  Zhi-bin Ma,et al.  Arsenic trioxide induces apoptosis of human gastrointestinal cancer cells. , 2014, World journal of gastroenterology.

[5]  Juan Wang,et al.  TIFA suppresses hepatocellular carcinoma progression via MALT1-dependent and -independent signaling pathways , 2016, Signal Transduction and Targeted Therapy.

[6]  J. Li,et al.  TIFA, an inflammatory signaling adaptor, is tumor suppressive for liver cancer , 2015, Oncogenesis.

[7]  Shigeyoshi Itohara,et al.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.

[8]  Jie Zheng,et al.  Arsenic trioxide inhibits cell proliferation and human papillomavirus oncogene expression in cervical cancer cells. , 2014, Biochemical and biophysical research communications.

[9]  Minhong Yan,et al.  Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis , 2006, Nature.

[10]  R. Xiang,et al.  M2 tumour-associated macrophages contribute to tumour progression via legumain remodelling the extracellular matrix in diffuse large B cell lymphoma , 2016, Scientific Reports.

[11]  Limin Li,et al.  Long‐term efficacy and safety of arsenic trioxide for first‐line treatment of elderly patients with newly diagnosed acute promyelocytic leukemia , 2013, Cancer.

[12]  S. Kogan,et al.  Retinoic Acid and Arsenic Synergize to Eradicate Leukemic Cells in a Mouse Model of Acute Promyelocytic Leukemia , 1999, The Journal of experimental medicine.

[13]  M. Kudo,et al.  Signaling Pathways Governing Tumor Angiogenesis , 2011, Oncology.

[14]  Shan Jiang,et al.  ICAM3 mediates inflammatory signaling to promote cancer cell stemness. , 2018, Cancer letters.

[15]  Wancai Yang,et al.  ICAM3 mediates tumor metastasis via a LFA-1-ICAM3-ERM dependent manner. , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[16]  M. Siddiqui,et al.  Arsenic trioxide-mediated oxidative stress and genotoxicity in human hepatocellular carcinoma cells , 2013, OncoTargets and therapy.

[17]  Jianping Zhang,et al.  Inhibition of transforming growth factor beta/SMAD signal by MiR-155 is involved in arsenic trioxide-induced anti-angiogenesis in prostate cancer , 2014, Cancer science.

[18]  M. Colombo,et al.  VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE‐1 study , 2014, International journal of cancer.

[19]  Wenzhi Shen,et al.  TBX21 predicts prognosis of patients and drives cancer stem cell maintenance via the TBX21–IL-4 pathway in lung adenocarcinoma , 2018, Stem Cell Research & Therapy.

[20]  J. Folkman,et al.  Incipient angiogenesis. , 2000, Journal of the National Cancer Institute.

[21]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[22]  J. Folkman,et al.  ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESIS , 1971, The Journal of experimental medicine.

[23]  J. Karlsson,et al.  Arsenic trioxide is highly cytotoxic to small cell lung carcinoma cells , 2009, Molecular Cancer Therapeutics.

[24]  K. Alitalo,et al.  VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. , 2009, Current opinion in cell biology.

[25]  Guang-Biao Zhou,et al.  From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia. , 2011, Blood.

[26]  Xiu-xia Zhou,et al.  Arsenic Trioxide Inhibits Cell Growth and Invasion via Down- Regulation of Skp2 in Pancreatic Cancer Cells. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[27]  Wei Zhou,et al.  Silencing PPA1 inhibits human epithelial ovarian cancer metastasis by suppressing the Wnt/β-catenin signaling pathway. , 2017, Oncotarget.

[28]  M. Fu,et al.  Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo. , 2007, Gynecologic oncology.

[29]  Ying Chen,et al.  VEGF and SEMA4D have synergistic effects on the promotion of angiogenesis in epithelial ovarian cancer , 2018, Cellular & Molecular Biology Letters.

[30]  Johanna Andrae,et al.  Role of platelet-derived growth factors in physiology and medicine. , 2008, Genes & development.

[31]  D. Cheresh,et al.  Tumor angiogenesis: molecular pathways and therapeutic targets , 2011, Nature Medicine.

[32]  Yihai Cao,et al.  R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways , 2008, Journal of Molecular Medicine.

[33]  Gavin Thurston,et al.  Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis , 2006, Nature.

[34]  Shuzhao Jia,et al.  Arsenic trioxide induces G2/M arrest in hepatocellular carcinoma cells by increasing the tumor suppressor PTEN expression , 2012, Journal of cellular biochemistry.

[35]  M. Bookman.  Should studies of maintenance therapy be maintained in women with ovarian cancer? , 2013, Journal of gynecologic oncology.

[36]  J. Quigley,et al.  Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions. , 2010, Biochimica et biophysica acta.